BRPI1006875A2 - composição farmacêutica, bactérias, uso de bactérias vivas, e, métodos para tratar um animal. - Google Patents

composição farmacêutica, bactérias, uso de bactérias vivas, e, métodos para tratar um animal.

Info

Publication number: BRPI1006875A2
Authority: BR; Brazil
Prior art keywords: bacteria; animal; treating; methods; pharmaceutical composition
Prior art date: 2009-01-12

Application number

BRPI1006875A

Other languages

English (en)

Inventor

Antonius Arnaldus Christiaan Jacobs

Lubbert Dijkhuizen

Robert Van Der Geize

Original Assignee

Intervet Int Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-01-12

Filing date

2010-01-11

Publication date

2016-08-09

2010-01-11 Application filed by Intervet Int Bv filed Critical Intervet Int Bv

2016-08-09 Publication of BRPI1006875A2 publication Critical patent/BRPI1006875A2/pt

2020-10-20 Publication of BRPI1006875B1 publication Critical patent/BRPI1006875B1/pt

2021-05-25 Publication of BRPI1006875B8 publication Critical patent/BRPI1006875B8/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Microbiology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
General Chemical & Material Sciences (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

BRPI1006875A 2009-01-12 2010-01-11 composição farmacêutica, bactérias, e, uso de bactérias vivas BRPI1006875B8 (pt)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US14386909P	2009-01-12	2009-01-12
EP09150379		2009-01-12
US61/143869		2009-01-12
EP09150379.7		2009-01-12
PCT/EP2010/050196 WO2010079224A1 (en)	2009-01-12	2010-01-11	Pharmaceutical composition to protect an animal against a disorder arising from an infection with a bacterium that belongs to the group of nocardioform actinomycetes

Publications (3)

Publication Number	Publication Date
BRPI1006875A2 true BRPI1006875A2 (pt)	2016-08-09
BRPI1006875B1 BRPI1006875B1 (pt)	2020-10-20
BRPI1006875B8 BRPI1006875B8 (pt)	2021-05-25

Family

ID=40756390

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI1006875A BRPI1006875B8 (pt)	2009-01-12	2010-01-11	composição farmacêutica, bactérias, e, uso de bactérias vivas

Country Status (14)

Country	Link
US (1)	US8574565B2 (pt)
EP (1)	EP2385836B1 (pt)
JP (1)	JP5540325B2 (pt)
CN (1)	CN102271693B (pt)
AR (1)	AR075013A1 (pt)
AU (1)	AU2010204269B2 (pt)
BR (1)	BRPI1006875B8 (pt)
CA (1)	CA2749075C (pt)
MX (1)	MX2011007414A (pt)
NZ (1)	NZ593588A (pt)
RU (1)	RU2543663C2 (pt)
TW (1)	TWI458489B (pt)
WO (1)	WO2010079224A1 (pt)
ZA (1)	ZA201104714B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP5520389B2 (ja) *	2010-01-04	2014-06-11	インターベットインターナショナルベー．フェー．	ロドコッカス・エクイに対する動物保護用組成物のための投与経路
CA2951900A1 (en) *	2014-06-10	2015-12-17	Georgia State University And Research Foundation, Inc.	Inhibiting or reducing fungal infections
CN104232535B (zh) *	2014-09-02	2017-04-26	广东海洋大学	鰤鱼诺卡氏菌诱变弱毒株及其应用
CN105622422B (zh) *	2016-01-29	2017-12-05	南开大学	一类溴代六氢茚酮类化合物及其制备方法和用途
WO2020145663A1 (ko) *	2019-01-09	2020-07-16	주식회사 엠디헬스케어	로도코커스 속 세균 유래 나노소포 및 이의 용도
CN113264878B (zh) *	2019-11-11	2022-05-27	山东畜牧兽医职业学院	一种用于畜牧业治疗耐药性微生物菌的化合物的制备方法
CN112746050B (zh) *	2020-12-22	2021-12-24	广东海洋大学深圳研究院	一种鰤鱼诺卡氏菌减毒株及其制备方法和应用
WO2025163760A1 (ja) *	2024-01-30	2025-08-07	国立研究開発法人水産研究・教育機構	弱毒性細菌株、弱毒生ワクチン、防除方法、及び生産方法
CN117903997B (zh) *	2024-02-26	2024-12-20	山东格研生物技术有限公司	一种马红球菌选择性分离培养基及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5721242A (en) *	1993-06-17	1998-02-24	Hoffmann-La Roche Inc.	Antibiotic combination
CA2298558A1 (en) *	1997-07-28	1999-02-04	Temple University - Of The Commonwealth System Of Higher Education	Genetically engineered rhodococcus vaccine
NZ538163A (en) *	2002-07-16	2008-04-30	Harvard College	Rhodococcus equi mutants and vaccines comprising same
US8481530B2 (en)	2006-12-01	2013-07-09	The Research Foundation Of State University Of New York	3β-hydroxysteroid dehydrogenase inhibitors
WO2009024572A1 (en) *	2007-08-21	2009-02-26	N.V. Organon	Method for the production of modified steroid degrading microorganisms and their use

2010
- 2010-01-11 EP EP10700058.0A patent/EP2385836B1/en active Active
- 2010-01-11 NZ NZ593588A patent/NZ593588A/xx not_active IP Right Cessation
- 2010-01-11 CA CA2749075A patent/CA2749075C/en not_active Expired - Fee Related
- 2010-01-11 RU RU2011133824/10A patent/RU2543663C2/ru not_active IP Right Cessation
- 2010-01-11 CN CN2010800042945A patent/CN102271693B/zh not_active Expired - Fee Related
- 2010-01-11 US US13/144,042 patent/US8574565B2/en active Active
- 2010-01-11 AU AU2010204269A patent/AU2010204269B2/en not_active Ceased
- 2010-01-11 WO PCT/EP2010/050196 patent/WO2010079224A1/en not_active Ceased
- 2010-01-11 BR BRPI1006875A patent/BRPI1006875B8/pt not_active IP Right Cessation
- 2010-01-11 MX MX2011007414A patent/MX2011007414A/es active IP Right Grant
- 2010-01-11 JP JP2011544878A patent/JP5540325B2/ja not_active Expired - Fee Related
- 2010-01-11 TW TW099100577A patent/TWI458489B/zh not_active IP Right Cessation
- 2010-01-12 AR ARP100100066A patent/AR075013A1/es unknown
2011
- 2011-06-24 ZA ZA2011/04714A patent/ZA201104714B/en unknown

Also Published As

Publication number	Publication date
CA2749075C (en)	2017-02-21
TWI458489B (zh)	2014-11-01
TW201036631A (en)	2010-10-16
AU2010204269B2 (en)	2015-05-07
CN102271693A (zh)	2011-12-07
BRPI1006875B8 (pt)	2021-05-25
JP2012515147A (ja)	2012-07-05
RU2011133824A (ru)	2013-02-20
RU2543663C2 (ru)	2015-03-10
AU2010204269A1 (en)	2011-08-04
CA2749075A1 (en)	2010-07-15
AR075013A1 (es)	2011-03-02
NZ593588A (en)	2012-12-21
ZA201104714B (en)	2012-03-28
WO2010079224A1 (en)	2010-07-15
US20110274660A1 (en)	2011-11-10
CN102271693B (zh)	2013-11-06
BRPI1006875B1 (pt)	2020-10-20
MX2011007414A (es)	2012-03-16
EP2385836B1 (en)	2016-05-25
US8574565B2 (en)	2013-11-05
JP5540325B2 (ja)	2014-07-02
EP2385836A1 (en)	2011-11-16

Similar Documents

Publication	Publication Date	Title
BRPI1006875A2 (pt)	2016-08-09	composição farmacêutica, bactérias, uso de bactérias vivas, e, métodos para tratar um animal.
BRPI1009920A2 (pt)	2016-03-15	composições bacterianas para profilaxina e tratamento de doença degenerativa.
EA201270566A1 (ru)	2012-11-30	Противомикробные соединения и способы их получения и применения
CR11731A (es)	2011-06-08	Composiciones y procedimientos para su preparación y uso
BR112012022878A2 (pt)	2016-06-14	composto, composição farmacêutica, uso do compostos e método de tratamento
BR112014010186A2 (pt)	2017-05-02	formulação farmacêutica estável, kit, composição farmacêutica, método para preparar uma formulação farmacêutica, e, método para tratar um humano ou animal
BR112012022879A2 (pt)	2016-06-14	composto, composição farmacêutica, uso do composto e método de tratamento
BR112012003092A2 (pt)	2016-11-29	composições e métodos para implantação de tecido adiposo processado e produtos de tecido adiposo processados.
BRPI1013984A2 (pt)	2018-06-19	composto , composição farmacêutica, método para tratamento ou profilaxia de uma doença ou condição, e, uso de um composto.
EA201270567A1 (ru)	2012-12-28	Противомикробные соединения и способы их получения и применения
BR112012018951A2 (pt)	2017-06-27	composição farmacêutica, combinação farmacêutica e método para o tratamento e\ou prevenção de um câncer e anticorpo
MX379016B (es)	2025-03-10	Composiciones y metodos para tratar enfermedad de gaucher.
BR112012018947A8 (pt)	2017-12-19	composição farmacêutica para o tratamento e/ou prevenção de um câncer, anticorpo, combinação farmacêutica e método para o tratamento e/ou prevenção de um câncer
BRPI0918359A2 (pt)	2015-12-15	composto, composição agroquímica, uso da composição agroquímica e método para preparação do composto
BR112013014583A2 (pt)	2016-09-20	composição farmacêutica, e, métodos para o tratamento de inflamação, para o tratamento da dor, e para preparar 3-metanossulfonilpropionitrila
BRPI1009923A2 (pt)	2015-08-25	Método para controlar crescimento de plantas indesejáveis, uso do composto, e, composto.
BRPI0913300A2 (pt)	2018-05-22	composto, processo para o preparo e uso do mesmo, método de tratamento de infecção bacteriana em um animal, e, composição farmacêutica.
BR112013004456A2 (pt)	2016-06-07	composição para tratamento de planta, e, método para o tratamento de plantas
CL2014002348A1 (es)	2015-01-23	Compuestos derivados de fenicol; composicion farmaceutica que los comprende; y su uso para controlar o tratar infecciones bacterianas en ganado.
BR112012003842A2 (pt)	2016-03-22	composição farmacêutica, método de formulação e uso da mesma
BR112013032876A2 (pt)	2017-01-24	uso de formulações, e, método para fertilizar plantas
BRPI1006238A2 (pt)	2015-09-15	método para o tratamento pesticida de plantações e composição
BRPI1007929A2 (pt)	2015-09-01	"métodos e composições para o tratamento de neovascularização".
CL2015001772A1 (es)	2016-01-15	Composición farmacéutica para el tratamiento de dolor cabeza, y método de preparación de la misma.
BR112012002001A2 (pt)	2016-05-10	método para tratar uma doença e/ou distúrbio do olho, formulação farmacêutica, e, kit

Legal Events

Date	Code	Title	Description
2017-10-03	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2017-10-10	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2019-03-26	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]	Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI
2019-07-16	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2020-08-11	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2020-10-20	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 20/10/2020, OBSERVADAS AS CONDICOES LEGAIS.
2021-05-25	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/01/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF
2022-11-08	B21F	Lapse acc. art. 78, item iv - on non-payment of the annual fees in time	Free format text: REFERENTE A 13A ANUIDADE.
2023-02-28	B24J	Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)	Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2705 DE 08-11-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.